Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients
IntroductionThe benefit of secondary prevention in hypertensive patients with peripheral arterial disease (PAD) is based on continual simultaneous taking of statins, antiplatelet agents and antihypertensive agents, preferably angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor b...
Saved in:
| Main Authors: | Martin Wawruch, Miriam Petrova, Denisa Celovska, Sofa D. Alfian, Tomas Tesar, Jan Murin, Michal Trnka, Tomas Paduch, Emma Aarnio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1464689/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newly Started Versus Previously Treated Statin Patients: A Retrospective Cohort Study Comparing Adherence and Persistence with Reference to Cardiovascular Prevention
by: Marta Martín-Fernández, et al.
Published: (2025-04-01) -
Statins: Adherence and side-effects
by: D.J. Blom
Published: (2011-07-01) -
Despite the pandemic: upward trajectories of medication adherence and persistence in patients with dyslipidemia
by: Jieun Jang, et al.
Published: (2024-12-01) -
Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)
by: Sepideh Attal, et al.
Published: (2024-04-01) -
APPROACHES TO STATIN THERAPY ADHERENCE IMPROVEMENT
by: S. A. Shalnova, et al.
Published: (2018-04-01)